Recent UK decision in epic Neurim v Mylan patent battle may benefit generics seeking to stay injunctions
The country's courts continue to show great flexibility in an unusual dispute involving insomnia treatment Circadin
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.